Cutaneous adverse reactions to fluoroquinolones

Dermatitis

Volumn 22, Issue 3, 2011, Pages 155-160

  Kulthanan, Kanokvalai ^a   Chularojanamontri, Leena ^a   Manapajon, Araya ^a   Dhana, Naruemon ^a   Jongjarearnprasert, Kowit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIRETROVIRUS AGENT; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; GATIFLOXACIN; IMIPENEM; ISONIAZID; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RUFLOXACIN; SULFONAMIDE; TETRACYCLINE; VANCOMYCIN;

ADULT; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; CLINICAL ASSESSMENT; COMORBIDITY; CROSS ALLERGY; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; DYSLIPIDEMIA; ECZEMA; EDEMA; ERYTHEMA MULTIFORME; ERYTHRODERMA; FEMALE; FIXED DRUG ERUPTION; FOOD ALLERGY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INJECTION SITE REACTION; KIDNEY FAILURE; LICHENOID ERUPTION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; NONSPECIFIC ECZEMA; NONSPECIFIC EDEMA; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SHRIMP; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; URTICARIAL VASCULITIS; VASCULITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG ERUPTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THAILAND;

EID: 79957606087     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2011.10115     Document Type: Article

References (28)

1. al-Hedaithy MA, Noreddin AM. Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS. Ann Pharmacother 1996;30:612-4.
2. Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther 2010;32:515-26, doi:10.1016/j.clinthera.2010.03.002.
3. Pulcini C, Mondain V, Lieutier F, et al. Fluoroquinolone prescriptions in a teaching hospital: a prospective audit. Scand J Infect Dis 2007;39:1013-7, doi:10.1080/00365540701466223. (Pubitemid 350153873)
4. Gonzalez I, Lobera T, Blasco A, Del Pozo MD. Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. J Investig Allergol Clin Immunol 2005;15:146-9. (Pubitemid 41020177)
5. Bertino J Jr, Fish D. The safety profile of the fluoroquinolones. Clin Ther 2000;22:798-817, doi:10.1016/S0149-2918(00)80053-3. (Pubitemid 30625913)
6. Ball P. Adverse reactions and interactions of fluoroquinolones. Clin Invest Med 1989;12:28-34. (Pubitemid 19043139)
7. Hallgren J, Tengvall-Linder M, Persson M, Wahlgren CF. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug. J Am Acad Dermatol 2003;49:267-9, doi:10.1016/S0190-9622(03)00478-X.
8. Weaver CH, Huddleston HM, Kingsley MM, Wolverton SE. Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis. J Drugs Dermatol 2009;8:1031-3.
9. World Health Organization: The use of the WHO-UMC system for standardised case causality assessment. Available at: http://www.who-umc.org/graphics/4409. pdf (accessed October 11, 2010).
10. Puavilai S, Noppakun N, Sitikalin C, et al. Drug eruptions at five institutes in Bangkok. J Med Assoc Thai 2005;88:1642-50. (Pubitemid 44698982)
11. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003;3:275-81, doi:10.1097/00130832-200308000-00007. (Pubitemid 37010883)
12. Harmsze AM, Deneer VH, Maitland-van der Zee AH, et al. Genetic variations affect drug safety and efficacy [abstract]. Ned Tijdschr Geneeskd 2010;154:A1503.
13. Lee A, Thompson J. Drug-induced skin reactions. 2006. Available at: http://www.pharmpress.com/shop/samples/ADRe2Ch05.pdf (accessed October 11, 2010).
14. Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol 2003;83:1-9, doi:10.1080/00015550310002611. (Pubitemid 36223045)
15. Bachot N, Roujeau JC. Physiopathology and treatment of severe drug eruptions. Curr Opin Allergy Clin Immunol 2001;1:293-8.
16. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 1993;46:1323-30, doi:10.1016/0895-4356(93)90101-6. (Pubitemid 23333873)
17. Sachs B, Riegel S, Seebeck J, et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006;29:1087-100, doi:10.2165/00002018-200629110-00008. (Pubitemid 44912717)
18. Lapi F, Tuccori M, Motola D, et al. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 2010;33:789-99, doi:10.2165/11536810-000000000-00000.
19. Despotovic N, Bojovic I, Paranos S, et al. Atopy and drug allergy. Srp Arh Celok Lek 1994;122:92-3.
20. Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004;113:155-60, doi:10.1016/j.jaci.2003.09. 035. (Pubitemid 38096176)
21. Dang PK, Degand G, Danyi S, et al. Validation of a two-plate microbiological method for screening antibiotic residues in shrimp tissue. Anal Chim Acta 2010;672:30-9, doi:10.1016/j.aca.2010.03.055.
22. Davila I, Diez ML, Quirce S, et al. Cross-reactivity between quinolones. Allergy 1993;48:388-90, doi:10.1111/j.1398-9995.1993.tb02413.x.
23. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005;5:15-21, doi:10.1007/s11882-005-0049-1. (Pubitemid 40310252)
24. Cheriyan S, Patterson R, Greenberger PA, et al. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc 1995;16:151-5, doi:10.2500/108854195778666793.
25. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85, doi:10.1056/NEJM199411103311906. (Pubitemid 24333193)
26. Chave TA, Mortimer NJ, Sladden MJ, et al. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153:241-53, doi:10.1111/j.1365-2133.2005.06721.x. (Pubitemid 41228420)
27. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87:144-8, doi:10.2340/00015555-0214. (Pubitemid 46513200)
28. Tokura Y. Quinolone photoallergy: photosensitivity dermatitis induced by systemic administration of photohaptenic drugs. J Dermatol Sci 1998;18:1-10, doi:10.1016/S0923-1811(98)00026-7. (Pubitemid 28404880)